Pharmathek Listed by akira Ransomware Group: Ransomware Claim — What’s Alleged & What To Do
Pharmathek was listed by the Akira ransomware group on April 17, 2026, after internal files were exfiltrated in a ransomware attack affecting an undisclosed number of people. Individuals should check whether their data may have been exposed and take appropriate protective steps.
Breaking down the breach
The only confirmed public detail is the listing itself on April 17, 2026. No information has been released about the date of the intrusion, the initial access vector, the volume of data taken, or whether any files were subsequently published. The group stated that corporate data would be uploaded, but no independent verification of that material has appeared in open sources.
The group behind it: akira
Akira is a ransomware operation that first appeared in early 2023 and has since conducted intrusions against organizations in North America, Europe, and Asia. The group typically employs double-extortion tactics: encrypting systems and threatening to publish stolen files if a ransom is not paid. Its leak-site listings function as a pressure mechanism rather than an automatic confirmation that every claimed dataset will be released.
Who is Pharmathek?
Pharmathek develops, produces, and installs automated storage and robotic systems designed for pharmacies. Its product line includes the third-generation SINTESI robot, which features customizable interfaces and smartphone connectivity. Firms in this niche routinely hold engineering documentation, client contracts, and operational records that can contain both commercial and personal information.
The information in question
The listing refers only to “internal files exfiltrated in ransomware attack.” The group claims it possesses additional material, but the precise contents have not been independently confirmed. Organizations of this type commonly store engineering specifications, client agreements, employee records, and financial documentation; whether any of those categories were actually taken remains undisclosed.
- Passports and contact details of clients and employees
- Financial records
- Project documentation and NDAs
What's at stake
Exposure of employee or client identity documents can facilitate identity theft or targeted fraud. Project files and NDAs may reveal proprietary designs or contractual terms, creating commercial risk for the company and its partners. Because the scale of the data remains unknown, the practical impact on any individual cannot yet be quantified.
Were you affected?
Pharmathek has not published a notification process. Individuals can monitor official statements from the company and review any correspondence they have received. Running a free exposure scan of an email address against known breach repositories provides one immediate way to check whether personal information has already appeared in public data sets.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
HRC Sicherheitsdienste Listed by akira Ransomware GroupMaschinen-Stockert Listed by akira Ransomware GroupAllele Diagnostics Listed by akira Ransomware GroupGreenwoods Dental Centre Listed by akira Ransomware GroupLatest breaches
Read GalaxyWarden’s full analysis of the Pharmathek Listed by akira Ransomware Group →
Publicly posted by akira — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.